secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000950170-23-027259
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEAYA Biosciences increases director stock option grants; votes at annual meeting
--------------------------------------------------------------------------------

- Initial director stock option grant increased from 22,000 to 32,400 shares.
- Annual director stock option grant increased from 11,000 to 16,200 shares.
- Three Class I directors elected: Yujiro Hata (41.3M for), Garrett Hampton (36.4M), Catherine Mackey (41.0M).
- Ratification of PricewaterhouseCoopers as auditor for 2023 with 44.6M for, 49,514 against.
- Board approved compensation changes on June 6, 2023, based on peer group data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000095017023027259/0000950170-23-027259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000095017023027259/idya-20230606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer